Keywords: boeh, ingelheim, reports, financial, growth, boehringer, reported
Boeh Ingelheim reports 8.2% financial growth
Article | 15 April 2002
Boehringer Ingelheim has reported year-on-year growth of 8.2% for fiscalyear 2001, as sales reached 6.7 billion euros ($5.86 billion). For the year, operating income ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
